Johnson & Johnson
JNJ
#21
Rank
NZ$1.219 T
Marketcap
NZ$506.70
Share price
-1.36%
Change (1 day)
43.57%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): NZ$11.64

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$12.14. In 2025 the company made an earnings per share (EPS) of NZ$20.25 an increase over its 2024 EPS that were of NZ$12.17.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.64-42.51%
2025NZ$20.2566.46%
2024NZ$12.17-53.6%
2023NZ$26.22111.16%
2022NZ$12.42-13.84%
2021NZ$14.4141.81%
2020NZ$10.16-18.92%
2019NZ$12.5321.2%
2018NZ$10.341125.3%
2017NZ$0.84-92.23%
2016NZ$10.867.37%
2015NZ$10.11-4.16%
2014NZ$10.5518.1%
2013NZ$8.9324.88%
2012NZ$7.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.55-21.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.29-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.92-59.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.42-38.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$56.16 362.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.60-70.35%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ-$5.64-146.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$17.18 41.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.23-56.92%๐Ÿ‡ฌ๐Ÿ‡ง UK